The latest move builds on the agency's decision in September to add semaglutide and tirzepatide, active ingredients in Novo Nordisk's Ozempic and Eli Lilly's Mounjaro, to its essential medicines list for managing type 2 diabetes in high-risk groups
Instead, it requires taking a medical approach and understanding why traditional methods, like a healthy diet and exercise, might not be enough
Easy to stay consistent and see results without disrupting your lifestyle
Table 2: Results of a 48-week retatrutide phase II trial(9) ID - Initial dose During the trial period about 94% of patients reported side effects while on retatrutide with most of them occurring in the 8mg and 12mg treatment groups and mostly during dose escalation.(13) These side effects were on average mild to moderate and included nausea (27%), diarrhea (13%), vomiting (10%), constipation (9%) and fatigue (7%)
Establishing a baseline of your current health To establish a comprehensive baseline of your current health status, the initial encounter will also include bloodwork, an electrocardiogram (EKG), and precise body measurements